Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...

For example, Nuvalent, Viridian Therapeutics and Cabaletta Bio have each said they could see disruptions ... Large pharma companies also face risks. Eli Lilly has tapped WuXi Apptec to produce some of ...

QIAGEN N.V. QGEN announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, a leading vaccines and diagnostics supplier to the Brazilian Ministry of Health. Initiated in 2009, ...

On Wednesday, Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $920.89 which represents a slight increase of $19.64 or 2.18% from the prior close of $901.25. The stock opened at ...

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said ...